A key component of cell division comes to light

June 30, 2014

The division of a cell in two requires the assembly of the mitotic spindle, an extremely complex structure, which is the result of the coordinated action of a multitude of proteins and a finely tuned balance of their activities. A large part of the time that a cell requires to divide is devoted to assembling the mitotic spindle, which, superficially, resembles a ball of thread with the shape of a rugby ball. The most abundant components of the spindle are the microtubules. "By labelling the ends of thousands of these fine filaments, which are indispensable and extremely dynamic and variable, we have finally been able to follow their distribution and movement during the assembly of the mitotic spindle," explains Jens Lüders, a cell biologist from the Institute for Research in Biomedicine (IRB Barcelona). The breakthrough appeared yesterday in the advanced online edition of the journal Nature Cell Biology.

"For more than 10 years we have been able to track only the growing ends of microtubules but not the starting points. As a result, we lacked essential information in order to understand the dynamic architecture of the mitotic spindle and how it contributes to cell division," says Lüders. Headed by the German scientist who runs the Microtubule Organisation Group at IRB Barcelona, the study carries only two names, his own and that of the French researcher Nicolas Lecland, first author, who completed his PhD at IRB Barcelona through a "la Caixa" fellowship.

The scientists have demonstrated that the protein γ-tubulin localizes at the starting points of the microtubule filaments and is relatively stably associated with these structures. Using a version of γ-tubulin that carries a fluorescent label activated by laser light, the researchers were able to follow the movement of the starting points of microtubules within mitotic spindles by filming dividing human cells. The Advanced Digital Microscopy Facility, a joint IRB Barcelona-Barcelona Science Park Facility run by the IRB physicist Julien Colombelli, has been crucial for setting up the technology required. "The success of this study is also the result of the technical know-how and cutting-edge technology available, without which we would never have been able to tackle this project," emphasizes Lüders.

The researchers describe for the first time where most microtubules form inside the mitotic spindle, how they develop, and how their starting points are transported--with the help of three motor proteins--to opposite poles of the spindle, where they attach. Simultaneous to this process, the opposite ends of the filaments extend towards the cell centre, where they interact with chromosomes. When the spindle is finally assembled, the microtubules pull the chromosomes to opposite poles and initiate the physical division of the cell. "We now have a more complete understanding of how the spindle assembles and functions and can use our novel marker for testing old and new hypotheses about underlying mechanisms," says the scientist.

A new tool to study cancer

In addition, the breakthrough paves the way to better understanding the mode of action of drugs that inhibit microtubules and that are used in chemotherapy. These kinds of drugs impede the mitotic spindle, thus preventing cell division and interfering with tumour growth.

In spite of the many years of clinical success of these treatments against cancer, little is known about how they impair spindle architecture and function. Although these drugs are highly efficient, they do not show the specificity desirable as they also affect healthy dividing cells. In addition, they affect non-dividing cells such as neurons, in which microtubules also have important functions. "A better understanding of the differences in spindle organisation between cancer and healthy cells and how they respond to microtubule-targeted drugs is essential in order to optimise treatments, for example by identifying more specific drugs or new targets. This tool could be useful to achieve these objectives," states the researcher.
-end-
The study has been supported by structural funds from the Generalitat de Catalunya, a Marie Curie grant from the European Union, and the Plan Nacional, of the Ministry of Economy and Competitiveness.

Reference article:

The dynamics of microtubule minus ends in the human mitotic spindle

Nicolas Lecland and Jens Lüders

Nature Cell Biology (2014) Doi: http://dx.doi.org/10.1038/ncb2996

Institute for Research in Biomedicine (IRB Barcelona)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.